Araceli Biosciences Inc.
Amendment
CIK: 0001975014·Other Technology·OREGON·Filed: Dec 8, 2025
Total Offering
$14,061,994
Amount Sold
$12,236,994
Investors
28
First Sale
Dec 31, 2024
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
Related Persons
| Name | Role |
|---|---|
| Matt Beaudet | Executive Officer, Director |
| Shawn MacDonald | Executive Officer |
| William Cortelyou | Director |
| Bruce Rhine | Director |
| Sean O'Neill | Director |
| J. William Freytag | Director |
| Kevin Gabelein | Director |
| Kirk Malloy | Director |
| Samraat Raha | Director |
Company
SEC Filing
0001975014-25-000004
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free